Evolving laser therapies for rosacea symptoms
Breakthroughs offer new options for treating telangiectasias and erythema
A number of medications are currently used to successfully treat and manage the clinical symptoms of papulopustular rosacea. Many of these patients however will also have clinical symptoms of erythematotelangiectatic rosacea, typically characterized by diffuse and persistent facial erythema and telangiectasias.
Recent advances in laser and light therapy are proving to be effective in managing the telangiectasias and erythema seen in a variety of dermatologic conditions, including rosacea, says. Roy G. Geronemus M.D., clinical professor of the Department of Dermatology at NYU Medical Center and director of the Laser & Skin Surgery Center of New York.
When addressing the diffuse facial erythema seen in rosacea and other conditions, Dr. Geronemus will either use a pulsed dye laser or the excel V laser, and employs the KTP laser for individual veins, where the veins are traced out in the procedure. According to Dr. Geronemus, who recently spoke at the 10th annual Laser & Aesthetic Skin Therapy course in Boston, the KTP laser is an excellent treatment option for linear blood vessels and identifiable individual blood vessels.
Here, a protocol may require anywhere from one to five or more treatment sessions, depending on the severity of the clinical symptoms. As telangiectasias and erythema is an ongoing process and will likely recur over time, Dr. Geronemus says that maintenance treatments will usually be required to maintain the clinical results achieved.